Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary HPV Screening as an Indicator of Cervical Pre-invasive and Invasive Neoplasia in HIV-positive and -Negative Southern African Women

NCT02956031 is registered in ClinicalTrials.gov with University of Pretoria as lead sponsor.

NCT NCT02956031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02956031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary HPV Screening as an Indicator of Cervical Pre-invasive and Invasive Neoplasia in HIV-positive and -Negative Southern African Women
Lead sponsor
University of Pretoria
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2016
Completion date
December 31, 2038
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cin2, high grade sil